PCMC
DGX icon

Paragon Capital Management (Colorado)’s Quest Diagnostics DGX Stock Holding History

Paragon Capital Management (Colorado)’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,699
Closed -$233K – 175
2022
Q1 		$233K Buy
1,699
+51
+3% +$7.11K 0.04% 142
2021
Q4 		$285K Sell
1,648
-18
-1% -$2.74K 0.05% 97
2021
Q3 		$242K Buy
1,666
+114
+7% +$16.7K 0.04% 108
2021
Q2 		$205K Buy
+1,552
New +$203K 0.1% 111

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

Paragon Capital Management (Colorado)'s DGX Position: Q2 2022 in Review

Paragon Capital Management (Colorado) sold out of Quest Diagnostics (DGX) in Q2 2022, closing a stake of 1,699 shares — an estimated $233K sold.

Paragon Capital Management (Colorado) first reported a position in DGX in Q2 2021 and held it in 4 quarters. The position peaked at $285K in Q4 2021. 851 funds tracked by Wall St. Rank hold DGX as of Q2 2022.

  • Paragon Capital Management (Colorado) reported no remaining Quest Diagnostics position as of Q2 2022 after selling out during the quarter.
  • Paragon Capital Management (Colorado) sold 1,699 Quest Diagnostics shares in Q2 2022, an estimated $233K.
  • Paragon Capital Management (Colorado) first reported a position in Quest Diagnostics in Q2 2021 and held it in 4 quarters.
  • Paragon Capital Management (Colorado)'s Quest Diagnostics position peaked at $285K in Q4 2021.
  • 851 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2022.

Based on Paragon Capital Management (Colorado)'s 13F filing for Q2 2022, filed 18 Jul 2022.